180 Life Sciences Corp. Continues To Expand Intellectual Property Portfolio
Yahoo! Finance
Notice of Allowance Issued for “Method for Reducing Post-Operative Cognitive Dysfunction (POCD)”PALO ALTO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it has received a Notice of Allowance, from the United States (US) Patent and Trade Office, for app
Continue Reading